Relafen 750, a powerful non-copyrightal NSAID, offers an unique biochemical view from the pharmacy standpoint. Relafen primarily operates by selectively inhibiting prostaglandin synthesis, thereby lessening pain and associated discomfort. Appreciating the mechanism of action – which is intricate relationship between enzyme suppression and subsequ